CN101983650A - Medicament for treating dermatitis aestivale - Google Patents
Medicament for treating dermatitis aestivale Download PDFInfo
- Publication number
- CN101983650A CN101983650A CN2010105036232A CN201010503623A CN101983650A CN 101983650 A CN101983650 A CN 101983650A CN 2010105036232 A CN2010105036232 A CN 2010105036232A CN 201010503623 A CN201010503623 A CN 201010503623A CN 101983650 A CN101983650 A CN 101983650A
- Authority
- CN
- China
- Prior art keywords
- grams
- medicament
- treatment
- dermatitis
- rhizoma atractylodis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating dermatitis aestivale. The component proportion of the medicament is as follows: phellodendron 6g, rhizoma atractylodis 6g, catnip 6g, common cnidium fruit 9g, windproof 6g and alum 3g. The accuracy of the ratio of the fixed dosages is plus or minus 10% of the above components. The medicament has the advantages of relieving itching, heat-clearing and detoxifying. The above medicament has an obvious and safe effect on treating dermatitis aestivale and is free of any toxic or side effect.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of dermatitis, a kind of specifically medicament for the treatment of dermatitis aestivale.
Background technology
Dermatitis refers to a kind of scytitis, represent the atopic reaction of skin for all materials such as chemicals, albumen, antibacterial and funguses, be the multiple season of dermatitis summer, yet at present at dermatitis, also neither one effective method for treatment or medicine, some medicines also contain hormone, and people are easily produced great toxic and side effects.
Summary of the invention
In order to solve the unfavorable problem of some curative effects at the medicine existence of treatment dermatitis, the invention provides a kind of medicament for the treatment of dermatitis aestivale, the medicament instant effect of this kind treatment dermatitis aestivale, drug effect is remarkable, safe and effective, and is without any side effects.
Concrete proportioning of the present invention is: Cortex Phellodendri 6 gram, Rhizoma Atractylodis 6 grams, Herba Schizonepetae 6 grams, Fructus Cnidii 9 grams, Radix Saposhnikoviae 6 grams, Alumen 3 grams, the degree of accuracy of the dose of this Chinese medicine be each medicine ± 10%.
Pharmacology of the present invention is: Cortex Phellodendri: heat clearing and damp drying, pathogenic fire purging are removed and are steamed, and skin ulcer is treated in detoxifcation; Rhizoma Atractylodis: drying damp and strengthening spleen, expelling wind and cold; Herba Schizonepetae: town's expectorant, timid wind, removing heat from blood; Fructus Cnidii: warming the kidney to invigorate YANG, dampness is dispeled the wind; Radix Saposhnikoviae: diseases caused by exogenous pathogenic factor exterior syndrome, rubella pruritus, rheumatic arthralgia; Alumen: quick-fried wet antipruritic, hemostasis antidiarrheal, heat clearing away expectorant.
Preparing process of the present invention: Cortex Phellodendri, Rhizoma Atractylodis, Herba Schizonepetae, Fructus Cnidii, Radix Saposhnikoviae, Alumen are endured slowly with clear water slow fire, treated that medicament is fried in shallow oil to remove slag after ripe to take concoction fumigation and wash method affected part when warm.
Administrated method of the present invention is: every day the fumigation and wash method affected part once.
The invention has the beneficial effects as follows: the medicament heat-clearing and toxic substances removing of this kind treatment dermatitis aestivale is antipruritic, and drug effect is remarkable, safe and effective, and is without any side effects.
Specific embodiment
Through over 3 years, the clinical practice to 100 examples are treated the patient of dermatitis has obtained curative effect preferably, and total effective rate reaches 95%, and details are as follows for relevant clinical treatment situation:
1. patient profile: select projects such as medical history, the state of an illness, age, sex and original therapy method.
2. patient originates: with general hospital patient and professional OH patient.
3. case is gone into the group standard, and according to the clinical manifestation and the pathological characters branch of treatment dermatitis, sex, age are not limit, stop using before the treatment other various medicines and therapeutic modality.
4. preparing process: Cortex Phellodendri, Rhizoma Atractylodis, Herba Schizonepetae, Fructus Cnidii, Radix Saposhnikoviae, Alumen are endured slowly with clear water slow fire, treated that medicament is fried in shallow oil to remove slag after ripe to take concoction fumigation and wash method affected part when warm.
5. administrated method: evening every day the fumigation and wash method affected part once.
6. efficacy evaluation
1. recovery from illness: transference cure, thoroughly recovery from illness.
2. remarkable: curing does not afterwards have recurrence more than 1 year.
3. effective: the complications shape of various dermatitis patients significantly reduces.
4. invalid: change not quite before and after the treatment, or once taking a turn for the better, after return to symptom before the treatment again.
7. efficacy analysis:
1. sex: according to going into the group standard, we treat dermatitis patients 100 examples altogether, male's 60 examples (60%) wherein, women's 40 examples (40%).
2. the course of disease: 6 months~1 year is 15 examples, and 2 years~3 years is 50 examples, is 35 examples more than 3 years.
3. age group: 20~30 years old 35 example, 31~40 years old 5 example, 41~50 years old 20 example, 51~60 years old 30 example, 10 examples more than 60 years old.
4. prepare the dose scheme for first kind: Cortex Phellodendri 6.6 grams, Rhizoma Atractylodis 6.6 grams, Herba Schizonepetae 6.6 grams, Fructus Cnidii 9.9 grams, Radix Saposhnikoviae 6.6 restrain, Alumen 3.3 grams.
The efficacy analysis of this scheme, administration time are 1~2 course of treatment.
Patient's type | Recovery from illness | Significantly | Effectively | Invalid |
Patients with mild 50 examples | 40 | 7 | 2 | 1 |
Moderate patient's 35 examples | 30 | 2 | 2 | 1 |
Severe patient 15 examples | 12 | 1 | 1 | 1 |
The scheme of second kind of preparation dose: Cortex Phellodendri 6 grams, Rhizoma Atractylodis 6 grams, Herba Schizonepetae 6 grams, Fructus Cnidii 9 grams, Radix Saposhnikoviae 6 grams, Alumen 3 grams.
The efficacy analysis of this scheme, administration time are 1~2 course of treatment.
Patient's type | Recovery from illness | Significantly | Effectively | Invalid |
Patients with mild 45 examples | 35 | 8 | 1 | 1 |
Moderate patient's 40 examples | 35 | 3 | 1 | 1 |
Severe patient 15 examples | 10 | 3 | 1 | 1 |
The scheme of the third preparation dose: Cortex Phellodendri 5.4 grams, Rhizoma Atractylodis 5.4 grams, Herba Schizonepetae 5.4 grams, Fructus Cnidii 8.1 grams, Radix Saposhnikoviae 5.4 grams, Alumen 2.7 grams.
The efficacy analysis of this scheme, administration time are 1~2 course of treatment.
Patient's type | Recovery from illness | Significantly | Effectively | Invalid |
Patients with mild 50 examples | 40 | 8 | 1 | 1 |
Moderate patient's 40 examples | 35 | 3 | 1 | 1 |
Severe patient 10 examples | 7 | 1 | 1 | 1 |
By Chinese medicine Drug therapy dermatitis of the present invention, received satisfied curative effect.The symptom of this disease is a lot, and this clinical experiment is divided into " slightly ", " moderate " and " seriously " several types according to clinical characters, and this clinical experiment is to carry out jointly at general hospital and special outpatient clinic.
Before this group case treatment, during most of patients was carried out, the treatment of doctor trained in Western medicine mode, but all do not obtain curative effect preferably, especially Western medicine is for oral administration, and side effect is bigger, and human body is developed immunity to drugs and causes very big toxic and side effects.In the process of taking Chinese medicine medicine of the present invention, must not take Western medicine and use injection, or other treats this sick medicine.The medicament heat-clearing and toxic substances removing of this kind treatment dermatitis aestivale is antipruritic, and drug effect is remarkable, safe and effective, and is without any side effects.
Claims (2)
1. medicament for the treatment of dermatitis aestivale is characterized in that: concrete proportioning of the present invention is Cortex Phellodendri 6 grams, Rhizoma Atractylodis 6 grams, Herba Schizonepetae 6 grams, Fructus Cnidii 9 grams, Radix Saposhnikoviae 6 grams, Alumen 3 grams, the degree of accuracy of the dose of this Chinese medicine be each medicine ± 10%.
2. a kind of medicament for the treatment of dermatitis aestivale according to claim 1 is characterized in that: Cortex Phellodendri, Rhizoma Atractylodis, Herba Schizonepetae, Fructus Cnidii, Radix Saposhnikoviae, Alumen are endured slowly with clear water slow fire, treated that medicament is fried in shallow oil to remove slag after ripe to take concoction fumigation and wash method affected part when warm.。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105036232A CN101983650A (en) | 2010-10-08 | 2010-10-08 | Medicament for treating dermatitis aestivale |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105036232A CN101983650A (en) | 2010-10-08 | 2010-10-08 | Medicament for treating dermatitis aestivale |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101983650A true CN101983650A (en) | 2011-03-09 |
Family
ID=43640813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010105036232A Pending CN101983650A (en) | 2010-10-08 | 2010-10-08 | Medicament for treating dermatitis aestivale |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101983650A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102784336A (en) * | 2012-08-23 | 2012-11-21 | 徐慧 | Traditional Chinese medicine compound lotion for clearing away heat and toxic materials and promoting diuresis and relieving itching and preparation method |
CN102949502A (en) * | 2012-10-29 | 2013-03-06 | 逄瑞莲 | Scalp folliculitis treatment external application traditional Chinese medicine |
CN103948804A (en) * | 2014-05-09 | 2014-07-30 | 蒋保珍 | Traditional Chinese medicinal composition for treating lung-qi deficiency type dermatitis aestivale |
-
2010
- 2010-10-08 CN CN2010105036232A patent/CN101983650A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102784336A (en) * | 2012-08-23 | 2012-11-21 | 徐慧 | Traditional Chinese medicine compound lotion for clearing away heat and toxic materials and promoting diuresis and relieving itching and preparation method |
CN102784336B (en) * | 2012-08-23 | 2014-01-29 | 马学英 | Traditional Chinese medicine compound lotion for clearing away heat and toxic materials and promoting diuresis and relieving itching and preparation method |
CN102949502A (en) * | 2012-10-29 | 2013-03-06 | 逄瑞莲 | Scalp folliculitis treatment external application traditional Chinese medicine |
CN103948804A (en) * | 2014-05-09 | 2014-07-30 | 蒋保珍 | Traditional Chinese medicinal composition for treating lung-qi deficiency type dermatitis aestivale |
CN103948804B (en) * | 2014-05-09 | 2017-01-04 | 任纪祯 | A kind of Chinese medicine composition treating lung qi deficiency dermatitis aestivale |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101961449B (en) | Traditional Chinese medicine for treating tinea corporis | |
CN104491220B (en) | A kind of traditional Chinese medicine composition for herpes | |
CN103463516B (en) | Traditional Chinese medicine ointment for treating dermatophytoses and preparation method thereof | |
CN101983644A (en) | Medicament for treating sequelae of apoplexy | |
CN101983717A (en) | Traditional Chinese medicine for treating migraine | |
CN101983650A (en) | Medicament for treating dermatitis aestivale | |
CN104095970B (en) | A kind of External apply medicinal wine for the treatment of verruca vulgaris | |
CN101983672A (en) | Medicament for treating cramp | |
CN104435557A (en) | Medicine for treating rheumatic arthralgia syndrome | |
CN101797308B (en) | External medicine for treating mastitis | |
CN101559125B (en) | Burning powder | |
CN101961455A (en) | Traditional Chinese medicine for treating chronic colitis disease | |
CN101979036A (en) | Medicinal liquor for treating rheumatic arthritis | |
CN101983682A (en) | Medicament for treating female climacteric metancholia | |
CN104524107A (en) | Chinese patent medicine for wind cold damp impediment symptom | |
CN108186807A (en) | A kind of Chinese medicine composition for treating perianal | |
CN103330792B (en) | Traditional Chinese medicine lotion for treating tinea pedes | |
CN103211946A (en) | Traditional Chinese medicine for treating gastric ulcer and duodenal ulcer | |
CN101983719A (en) | Novel medicament for treating lung cancer | |
CN102755453B (en) | A kind of fumigation-washing medicine treating chronic eczema of scrotum | |
CN101983681A (en) | Medicament for treating abnormal leucorrhea | |
CN101983712A (en) | Novel medicament for treating coronary heart disease | |
CN101632762A (en) | Traditional Chinese medicine ointment for treating child aphtha | |
CN101559185A (en) | External medicament for curing varicose vein of lower limbs | |
CN106361840A (en) | Traditional Chinese medicine composite used for treating rheumatism and preparing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110309 |